West Pharmaceutical Services Weighted-average dividend yield remained flat by 0.0% to 0.4% in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 0.4% to 0.4%. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher dividend yields generally decrease the fair value of stock options, lowering compensation expense.
The estimated annual dividend yield used in valuation models to determine the fair value of employee stock options. This...
Standard disclosure in the footnotes of financial statements for all public companies.
other_share_based_compensation_arrangement_by_share_base_c66307| Q1 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | 0.2% | 0.3% | 0.3% | 0.4% | 0.4% |
| QoQ Change | — | +50.0% | +0.0% | +33.3% | +0.0% |
| YoY Change | — | +50.0% | +0.0% | +33.3% | +0.0% |